<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03197038</url>
  </required_header>
  <id_info>
    <org_study_id>2016-1217</org_study_id>
    <secondary_id>P30AG022849</secondary_id>
    <nct_id>NCT03197038</nct_id>
  </id_info>
  <brief_title>Exercise Training and Cognitive Function in Kidney Disease</brief_title>
  <official_title>Exercise Training and Cognitive Function in Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Midwest Roybal Center for Health Promotion and Translation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic kidney disease (CKD), affects over 45% of all individuals over 70 years of age.&#xD;
      Patients with moderate CKD have more than a two-fold increased risk of cognitive impairment&#xD;
      than those without CKD; furthermore, as many as 20-70% of patients with CKD have established&#xD;
      cognitive impairment and overt dementia. The burden of cognitive impairment and dementia&#xD;
      leads to functional decline and accelerated loss of independence, contributing to the&#xD;
      tremendous individual, societal, and economic burden of CKD (i.e., 20% of Medicare&#xD;
      expenditures in adults &gt;65 years of age). There is no recommended treatment to prevent&#xD;
      cognitive decline in CKD patients, and the few medications available for cognitive impairment&#xD;
      have only short term modest effects. There is a critical need to evaluate therapies to&#xD;
      forestall cognitive impairment, and maintain or improve cognitive functioning in older&#xD;
      patients with CKD. To address this need, this study will test the hypothesis that older&#xD;
      patients with moderate/severe CKD and pre-clinical cognitive impairment randomized to a&#xD;
      6-month home-based exercise program will improve cognitive function and MRI measured brain&#xD;
      structure, compared to a usual care control group. This study will combine an assessment of&#xD;
      cognition with MR imaging techniques to fully evaluate brain structure, blood flow, and&#xD;
      behavior relationships at a level previously not conducted in this population&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Actual">December 18, 2019</completion_date>
  <primary_completion_date type="Actual">November 26, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, controlled design with a 1:1 allocation</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Global Cognitive Function</measure>
    <time_frame>Change from baseline in composite global cognitive function at 6 months</time_frame>
    <description>Determine the effect of a 6-month home-based exercise program on composite global cognitive functioning as determined by principal component analysis of immediate free recall of trials 1-5 on California verbal learning II, long-delay free recall and recognition, and memory discriminability, trail making test part A and part B, digit symbol substitution test, semantic and phonemic fluency, and Digit span subtest in older patients with kidney disease and preclinical cognitive impairment. A composite global cognitive score was created by converting the individual cognitive scores to standardized z scores and then averaging the standardized z scores. An increase in change from baseline to 6 months is considered an improvement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Composite Executive Function</measure>
    <time_frame>Change from baseline in composite executive function at 6 months</time_frame>
    <description>A composite executive functioning score was created by converting 4 individual executive cognitive scores (verbal fluency FAS and animal summary score, digit span backward subtest, and TMT-B) to standardized z scores and then averaging the standardized z scores. A larger change in Z score is considered an improvement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>White Matter Integrity</measure>
    <time_frame>Change from baseline white matter integrity fractional anisotropy at 6 months</time_frame>
    <description>Whole brain white matter integrity was created by averaging the fractional anisotropy of 80 tracts using region of interest analysis. An increased change from baseline to 6 months in fractional anisotropy (a measure of directionality, 0 = no principle direction, 1 = one principle direction) is considered an improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hippocampal Volume - Right</measure>
    <time_frame>Change from baseline hippocampal volume at 6 months.</time_frame>
    <description>Determine the effect of a 6-month exercise program on hippocampal volume. An increased change from baseline to 6 months in right hippocampal volume in cubic millimeters is considered an improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral Blood Flow</measure>
    <time_frame>Change from baseline in cerebral blood flow at 6 months.</time_frame>
    <description>Determine the effect of a 6-month exercise program on cerebral blood flow. Change in global cerebral blood measured in mL/100g/min from baseline to 6 months. An larger change is considered an improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular Health - Young's Elastic Modulus</measure>
    <time_frame>Change from baseline in vascular health indices at 6 months</time_frame>
    <description>Vascular health was assessed by Young's Elastic Modulus (YEM) at the carotid artery. A larger negative change in YEM (measured in kilo pascal, stiffer artery=higher number) from baseline to 6 months is considered an improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Function - Total Cognition</measure>
    <time_frame>Mean change from baseline to 6 months.</time_frame>
    <description>Determine the effect of a 6-month exercise program on cognitive function via the NIH toolbox&#xD;
This composite includes: Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used.&#xD;
Scale runs 140 to 23, a higher score means a better outcome. An increased change from baseline to 6 months is considered an improvement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor Function - Grip Strength</measure>
    <time_frame>Change from baseline in NIH toolbox motor function indices at 6 months</time_frame>
    <description>Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Age corrected grip strength on a standard scale. Standard scale 140-23, higher score is better. An increased change from baseline to 6 months is considered an improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular Health - Pulse Wave Velocity</measure>
    <time_frame>6 Months</time_frame>
    <description>Vascular function indices of vascular health was assessed using pulse wave velocity of the aorta in meters/second (higher number =more stiff aorta). A larger negative change from baseline to 6 months is considered an improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular Health - Augmentation Index</measure>
    <time_frame>6 Months</time_frame>
    <description>Vascular function indices of vascular health was assessed using augmentation index at the carotid artery (in percentage, higher percent=more stiff artery). A larger negative change from baseline to 6 months is considered an improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Function - Fluid Cognition</measure>
    <time_frame>Mean change from baseline to 6 months.</time_frame>
    <description>Determine the effect of a 6-month exercise program on cognitive function via the NIH toolbox. Fluid cognition.&#xD;
This composite includes: Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used. A larger change from baseline to 6 months is considered an improvement.&#xD;
Scale runs 140 to 23, a higher score means a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Function - Crystalized Cognition</measure>
    <time_frame>Mean change from baseline to 6 months.</time_frame>
    <description>Change from baseline in NIH toolbox cognitive function indices at 6 months. Crystalized cognition.&#xD;
This composite includes : Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used.&#xD;
An larger change from baseline to 6 months is considered an improvement. Scale runs 140 to 23, a higher score means a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor Function - Balance</measure>
    <time_frame>6 Months</time_frame>
    <description>Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Change in balance age corrected standard score from baseline to 6-months (23-140, higher score is better). A larger change is considered an improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor Function - Dexterity</measure>
    <time_frame>6 Months</time_frame>
    <description>Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Hand dexterity was determine using age corrected standard scale in the dominant hand. A larger change from baseline to 6 months is considered an improvement.&#xD;
Standard scale range 140-23, higher score is better.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting Global Connectivity</measure>
    <time_frame>Change from baseline at 6 months</time_frame>
    <description>Resting global connectivity measured and averaged across 132 regions. A larger change from baseline to 6 months is considered an improvement. Connectivity is a correlation (increased connectivity=higher correlation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hippocampal Volume - Left</measure>
    <time_frame>Change from baseline at 6 Months</time_frame>
    <description>Determine the effect of a 6-month exercise program on hippocampal volume. An larger change from baseline to 6 months in left hippocampal volume (cubic millimeters) is considered an improvement.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Cognitive Function, Preclinical</condition>
  <condition>Chronic Kidney Diseases</condition>
  <condition>Older Adults</condition>
  <arm_group>
    <arm_group_label>Home-based walking exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Partially supervised home-based walking exercise</intervention_name>
    <description>Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
    <arm_group_label>Home-based walking exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  English speaking men and women&#xD;
&#xD;
          -  diagnosed stage 3-5 CKD (eGFR&lt;60 to 15 ml/min);&#xD;
&#xD;
          -  60-80 years of age,&#xD;
&#xD;
          -  self-experienced persistent decline in cognitive capacity determined as self-reported&#xD;
             cognitive complaint (i.e., answering &quot;yes&quot; to the question: &quot;Do you feel like your&#xD;
             memory or thinking skills have gotten worse recently?&quot; (before any clinical impairment&#xD;
             of cognition has occurred)&#xD;
&#xD;
          -  ability to undergo an MRI;&#xD;
&#xD;
          -  no history of major head trauma.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ current/past diagnosis of neurological/psychiatric disorders;&#xD;
&#xD;
               -  any medications to improve cognition or mood;&#xD;
&#xD;
               -  Diagnosed Dementia or a score of &lt;2 on the mini-cog assessment&#xD;
&#xD;
               -  Ischemic ulcerations or gangrene on the feet or legs;&#xD;
&#xD;
               -  Participating in a supervised exercise program with intent to increase fitness&#xD;
                  levels 3 days/week,&#xD;
&#xD;
               -  Requires assistive ambulation;&#xD;
&#xD;
               -  Limited exercise capacity due to conditions other than claudication&#xD;
&#xD;
                    -  unstable angina,&#xD;
&#xD;
                    -  Claudication&#xD;
&#xD;
                    -  severe arthritis,&#xD;
&#xD;
                    -  extreme dyspnea on exertion,&#xD;
&#xD;
                    -  unstable coronary artery disease;&#xD;
&#xD;
                    -  Class III-IV heart failure;&#xD;
&#xD;
                    -  Current uncontrolled sustained arrhythmias,&#xD;
&#xD;
                    -  severe/symptomatic aortic or mitral stenosis,&#xD;
&#xD;
                    -  hypertrophic obstructive cardiomyopathy,&#xD;
&#xD;
                    -  severe pulmonary hypertension,&#xD;
&#xD;
                    -  active myocarditis/pericarditis,&#xD;
&#xD;
                    -  thrombophlebitis,&#xD;
&#xD;
                    -  recent systemic/pulmonary embolus (within 3 months);&#xD;
&#xD;
               -  Resting systolic BP &gt;200 mmHg or resting diastolic BP &gt;110 mmHg;&#xD;
&#xD;
               -  Revascularization procedures within the previous 6 months;&#xD;
&#xD;
               -  Any unforeseen illness or disability that would preclude exercise testing or&#xD;
                  training based on patient provider opinion;&#xD;
&#xD;
               -  Pregnancy&#xD;
&#xD;
               -  No diagnosis of CKD&#xD;
&#xD;
               -  One or more contraindication for MRI&#xD;
&#xD;
                    -  cardiac pacemaker,&#xD;
&#xD;
                    -  aneurysm clip,&#xD;
&#xD;
                    -  cochlear implants,&#xD;
&#xD;
                    -  shrapnel,&#xD;
&#xD;
                    -  history of metal fragments in eyes,&#xD;
&#xD;
                    -  neurostimulators,&#xD;
&#xD;
                    -  diagnosed claustrophobia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulf G Bronas, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 8, 2017</study_first_submitted>
  <study_first_submitted_qc>June 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2017</study_first_posted>
  <results_first_submitted>January 6, 2021</results_first_submitted>
  <results_first_submitted_qc>June 11, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">July 2, 2021</results_first_posted>
  <last_update_submitted>June 11, 2021</last_update_submitted>
  <last_update_submitted_qc>June 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Ulf G. Bronas</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Cognitive function</keyword>
  <keyword>Kidney Disease</keyword>
  <keyword>Exercise</keyword>
  <keyword>Older adults</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT03197038/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Home-based Walking Exercise</title>
          <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Home-based Walking Exercise</title>
          <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="39"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.68" spread="4.4"/>
                    <measurement group_id="B2" value="68.76" spread="5.7"/>
                    <measurement group_id="B3" value="67.6" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Composite Global Cognitive Function</title>
        <description>Determine the effect of a 6-month home-based exercise program on composite global cognitive functioning as determined by principal component analysis of immediate free recall of trials 1-5 on California verbal learning II, long-delay free recall and recognition, and memory discriminability, trail making test part A and part B, digit symbol substitution test, semantic and phonemic fluency, and Digit span subtest in older patients with kidney disease and preclinical cognitive impairment. A composite global cognitive score was created by converting the individual cognitive scores to standardized z scores and then averaging the standardized z scores. An increase in change from baseline to 6 months is considered an improvement.</description>
        <time_frame>Change from baseline in composite global cognitive function at 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Composite Global Cognitive Function</title>
          <description>Determine the effect of a 6-month home-based exercise program on composite global cognitive functioning as determined by principal component analysis of immediate free recall of trials 1-5 on California verbal learning II, long-delay free recall and recognition, and memory discriminability, trail making test part A and part B, digit symbol substitution test, semantic and phonemic fluency, and Digit span subtest in older patients with kidney disease and preclinical cognitive impairment. A composite global cognitive score was created by converting the individual cognitive scores to standardized z scores and then averaging the standardized z scores. An increase in change from baseline to 6 months is considered an improvement.</description>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".15" spread=".37"/>
                    <measurement group_id="O2" value=".02" spread=".33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Composite Executive Function</title>
        <description>A composite executive functioning score was created by converting 4 individual executive cognitive scores (verbal fluency FAS and animal summary score, digit span backward subtest, and TMT-B) to standardized z scores and then averaging the standardized z scores. A larger change in Z score is considered an improvement.</description>
        <time_frame>Change from baseline in composite executive function at 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Composite Executive Function</title>
          <description>A composite executive functioning score was created by converting 4 individual executive cognitive scores (verbal fluency FAS and animal summary score, digit span backward subtest, and TMT-B) to standardized z scores and then averaging the standardized z scores. A larger change in Z score is considered an improvement.</description>
          <units>Z score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread=".47"/>
                    <measurement group_id="O2" value="-.01" spread=".47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>White Matter Integrity</title>
        <description>Whole brain white matter integrity was created by averaging the fractional anisotropy of 80 tracts using region of interest analysis. An increased change from baseline to 6 months in fractional anisotropy (a measure of directionality, 0 = no principle direction, 1 = one principle direction) is considered an improvement.</description>
        <time_frame>Change from baseline white matter integrity fractional anisotropy at 6 months</time_frame>
        <population>Of the total sample of 39 participants, 31 participants were able to undergo MRI scans. Of these, four participants did not complete the study. Good quality data, without motion distortion , were available in 25 participants (two participants were excluded due to motion distortion) at baseline and follow-up and were included in the analysis (11 intervention participants and 14 control participants).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>White Matter Integrity</title>
          <description>Whole brain white matter integrity was created by averaging the fractional anisotropy of 80 tracts using region of interest analysis. An increased change from baseline to 6 months in fractional anisotropy (a measure of directionality, 0 = no principle direction, 1 = one principle direction) is considered an improvement.</description>
          <population>Of the total sample of 39 participants, 31 participants were able to undergo MRI scans. Of these, four participants did not complete the study. Good quality data, without motion distortion , were available in 25 participants (two participants were excluded due to motion distortion) at baseline and follow-up and were included in the analysis (11 intervention participants and 14 control participants).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.002" spread=".02"/>
                    <measurement group_id="O2" value=".003" spread=".01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hippocampal Volume - Right</title>
        <description>Determine the effect of a 6-month exercise program on hippocampal volume. An increased change from baseline to 6 months in right hippocampal volume in cubic millimeters is considered an improvement.</description>
        <time_frame>Change from baseline hippocampal volume at 6 months.</time_frame>
        <population>Of the total sample of 39 participants, 31 participants were able to undergo MRI scans. Of these, four participants did not complete the study. Good quality data, without motion distortion, were available in 21 participants (four participants were excluded due to motion distortion) at baseline and follow-up and were included in the analysis (9 intervention participants and 12 control participants).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Hippocampal Volume - Right</title>
          <description>Determine the effect of a 6-month exercise program on hippocampal volume. An increased change from baseline to 6 months in right hippocampal volume in cubic millimeters is considered an improvement.</description>
          <population>Of the total sample of 39 participants, 31 participants were able to undergo MRI scans. Of these, four participants did not complete the study. Good quality data, without motion distortion, were available in 21 participants (four participants were excluded due to motion distortion) at baseline and follow-up and were included in the analysis (9 intervention participants and 12 control participants).</population>
          <units>Cubic millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".003" spread=".0002"/>
                    <measurement group_id="O2" value=".003" spread=".003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cerebral Blood Flow</title>
        <description>Determine the effect of a 6-month exercise program on cerebral blood flow. Change in global cerebral blood measured in mL/100g/min from baseline to 6 months. An larger change is considered an improvement.</description>
        <time_frame>Change from baseline in cerebral blood flow at 6 months.</time_frame>
        <population>Of the total sample of 39 participants, 31 participants were able to undergo MRI scans. Of these, four participants did not complete the study. Good quality data, without motion distortion, were available in 25 participants (two participants were excluded due to motion distortion) at baseline and follow-up and were included in the analysis (11 intervention participants and 14 control participants).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Blood Flow</title>
          <description>Determine the effect of a 6-month exercise program on cerebral blood flow. Change in global cerebral blood measured in mL/100g/min from baseline to 6 months. An larger change is considered an improvement.</description>
          <population>Of the total sample of 39 participants, 31 participants were able to undergo MRI scans. Of these, four participants did not complete the study. Good quality data, without motion distortion, were available in 25 participants (two participants were excluded due to motion distortion) at baseline and follow-up and were included in the analysis (11 intervention participants and 14 control participants).</population>
          <units>mL/100gm/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="9.8"/>
                    <measurement group_id="O2" value="0.3" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vascular Health - Young's Elastic Modulus</title>
        <description>Vascular health was assessed by Young's Elastic Modulus (YEM) at the carotid artery. A larger negative change in YEM (measured in kilo pascal, stiffer artery=higher number) from baseline to 6 months is considered an improvement.</description>
        <time_frame>Change from baseline in vascular health indices at 6 months</time_frame>
        <population>Of the total sample of 39 participants, four participants did not complete the study. Good quality data, without motion distortion, were available in 33 participants (two participants were excluded due to motion distortion) at baseline and follow-up and were included in the analysis (17 intervention participants and 16 control participants).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Vascular Health - Young's Elastic Modulus</title>
          <description>Vascular health was assessed by Young's Elastic Modulus (YEM) at the carotid artery. A larger negative change in YEM (measured in kilo pascal, stiffer artery=higher number) from baseline to 6 months is considered an improvement.</description>
          <population>Of the total sample of 39 participants, four participants did not complete the study. Good quality data, without motion distortion, were available in 33 participants (two participants were excluded due to motion distortion) at baseline and follow-up and were included in the analysis (17 intervention participants and 16 control participants).</population>
          <units>Kilo pascals</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3,175" spread="9,428"/>
                    <measurement group_id="O2" value="1,279" spread="8,654"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cognitive Function - Total Cognition</title>
        <description>Determine the effect of a 6-month exercise program on cognitive function via the NIH toolbox&#xD;
This composite includes: Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used.&#xD;
Scale runs 140 to 23, a higher score means a better outcome. An increased change from baseline to 6 months is considered an improvement</description>
        <time_frame>Mean change from baseline to 6 months.</time_frame>
        <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Cognitive Function - Total Cognition</title>
          <description>Determine the effect of a 6-month exercise program on cognitive function via the NIH toolbox&#xD;
This composite includes: Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used.&#xD;
Scale runs 140 to 23, a higher score means a better outcome. An increased change from baseline to 6 months is considered an improvement</description>
          <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" spread="7.4"/>
                    <measurement group_id="O2" value="11" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Motor Function - Grip Strength</title>
        <description>Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Age corrected grip strength on a standard scale. Standard scale 140-23, higher score is better. An increased change from baseline to 6 months is considered an improvement.</description>
        <time_frame>Change from baseline in NIH toolbox motor function indices at 6 months</time_frame>
        <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Motor Function - Grip Strength</title>
          <description>Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Age corrected grip strength on a standard scale. Standard scale 140-23, higher score is better. An increased change from baseline to 6 months is considered an improvement.</description>
          <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" spread="6.2"/>
                    <measurement group_id="O2" value="-2.5" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vascular Health - Pulse Wave Velocity</title>
        <description>Vascular function indices of vascular health was assessed using pulse wave velocity of the aorta in meters/second (higher number =more stiff aorta). A larger negative change from baseline to 6 months is considered an improvement.</description>
        <time_frame>6 Months</time_frame>
        <population>Of the 39 participants that were enrolled, four did not complete the study. Good quality data without motion distortion at baseline and follow up was available in 30 participants (15=intervention, 15=control).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Vascular Health - Pulse Wave Velocity</title>
          <description>Vascular function indices of vascular health was assessed using pulse wave velocity of the aorta in meters/second (higher number =more stiff aorta). A larger negative change from baseline to 6 months is considered an improvement.</description>
          <population>Of the 39 participants that were enrolled, four did not complete the study. Good quality data without motion distortion at baseline and follow up was available in 30 participants (15=intervention, 15=control).</population>
          <units>Meters per second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.01" spread="1.1"/>
                    <measurement group_id="O2" value=".21" spread=".92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vascular Health - Augmentation Index</title>
        <description>Vascular function indices of vascular health was assessed using augmentation index at the carotid artery (in percentage, higher percent=more stiff artery). A larger negative change from baseline to 6 months is considered an improvement.</description>
        <time_frame>6 Months</time_frame>
        <population>Of the 39 participants enrolled, four did not complete the study. Good quality data without motion distortion at baseline and follow-up was available in 34 participants (18=intervention, 16=control).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Vascular Health - Augmentation Index</title>
          <description>Vascular function indices of vascular health was assessed using augmentation index at the carotid artery (in percentage, higher percent=more stiff artery). A larger negative change from baseline to 6 months is considered an improvement.</description>
          <population>Of the 39 participants enrolled, four did not complete the study. Good quality data without motion distortion at baseline and follow-up was available in 34 participants (18=intervention, 16=control).</population>
          <units>Percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="12.1"/>
                    <measurement group_id="O2" value="3.3" spread="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cognitive Function - Fluid Cognition</title>
        <description>Determine the effect of a 6-month exercise program on cognitive function via the NIH toolbox. Fluid cognition.&#xD;
This composite includes: Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used. A larger change from baseline to 6 months is considered an improvement.&#xD;
Scale runs 140 to 23, a higher score means a better outcome.</description>
        <time_frame>Mean change from baseline to 6 months.</time_frame>
        <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Cognitive Function - Fluid Cognition</title>
          <description>Determine the effect of a 6-month exercise program on cognitive function via the NIH toolbox. Fluid cognition.&#xD;
This composite includes: Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used. A larger change from baseline to 6 months is considered an improvement.&#xD;
Scale runs 140 to 23, a higher score means a better outcome.</description>
          <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" spread="12.2"/>
                    <measurement group_id="O2" value="11" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cognitive Function - Crystalized Cognition</title>
        <description>Change from baseline in NIH toolbox cognitive function indices at 6 months. Crystalized cognition.&#xD;
This composite includes : Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used.&#xD;
An larger change from baseline to 6 months is considered an improvement. Scale runs 140 to 23, a higher score means a better outcome.</description>
        <time_frame>Mean change from baseline to 6 months.</time_frame>
        <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Cognitive Function - Crystalized Cognition</title>
          <description>Change from baseline in NIH toolbox cognitive function indices at 6 months. Crystalized cognition.&#xD;
This composite includes : Flanker, Dimensional Change Card Sort, Picture Sequence Memory, List Sorting and Pattern Comparison. This composite score is derived by averaging the standard scores of each of the measures, and then deriving standard scores based on this new distribution. An Age-Corrected Standard Score was used.&#xD;
An larger change from baseline to 6 months is considered an improvement. Scale runs 140 to 23, a higher score means a better outcome.</description>
          <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" spread="7.5"/>
                    <measurement group_id="O2" value="8.3" spread="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Motor Function - Balance</title>
        <description>Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Change in balance age corrected standard score from baseline to 6-months (23-140, higher score is better). A larger change is considered an improvement.</description>
        <time_frame>6 Months</time_frame>
        <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Motor Function - Balance</title>
          <description>Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Change in balance age corrected standard score from baseline to 6-months (23-140, higher score is better). A larger change is considered an improvement.</description>
          <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6" spread="8.5"/>
                    <measurement group_id="O2" value="-8" spread="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Motor Function - Dexterity</title>
        <description>Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Hand dexterity was determine using age corrected standard scale in the dominant hand. A larger change from baseline to 6 months is considered an improvement.&#xD;
Standard scale range 140-23, higher score is better.</description>
        <time_frame>6 Months</time_frame>
        <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Motor Function - Dexterity</title>
          <description>Determine the effect of a 6-month exercise program on motor function via the NIH toolbox. Hand dexterity was determine using age corrected standard scale in the dominant hand. A larger change from baseline to 6 months is considered an improvement.&#xD;
Standard scale range 140-23, higher score is better.</description>
          <population>Data was collected in a sub-sample (n=12) to provide pilot data on the NIH-toolbox as part of an administrative supplement. Of the 12 participants that were part of the sub-sample, two did not complete the study. Baseline and follow-up data was available in 10 participants (6=intervention, 4=control).</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="4.5"/>
                    <measurement group_id="O2" value="1.8" spread="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Resting Global Connectivity</title>
        <description>Resting global connectivity measured and averaged across 132 regions. A larger change from baseline to 6 months is considered an improvement. Connectivity is a correlation (increased connectivity=higher correlation)</description>
        <time_frame>Change from baseline at 6 months</time_frame>
        <population>Resting global connectivity was collected in a sub-sample (n=12) to provide pilot data. Of the 12 participants that were part of the sub-sample, two did not complete the study. Good quality data without motion distortion at baseline and follow-up was available in 10 participants (5=intervention, 5=control).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Resting Global Connectivity</title>
          <description>Resting global connectivity measured and averaged across 132 regions. A larger change from baseline to 6 months is considered an improvement. Connectivity is a correlation (increased connectivity=higher correlation)</description>
          <population>Resting global connectivity was collected in a sub-sample (n=12) to provide pilot data. Of the 12 participants that were part of the sub-sample, two did not complete the study. Good quality data without motion distortion at baseline and follow-up was available in 10 participants (5=intervention, 5=control).</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".0047" spread=".0356"/>
                    <measurement group_id="O2" value="-.0310" spread=".019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hippocampal Volume - Left</title>
        <description>Determine the effect of a 6-month exercise program on hippocampal volume. An larger change from baseline to 6 months in left hippocampal volume (cubic millimeters) is considered an improvement.</description>
        <time_frame>Change from baseline at 6 Months</time_frame>
        <population>Of the total sample of 39 participants, 31 participants were able to undergo MRI scans. Of these, four participants did not complete the study. Good quality data, without motion distortion, were available in 21 participants (four participants were excluded due to motion distortion) at baseline and follow-up and were included in the analysis (9 intervention participants and 12 control participants).</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Walking Exercise</title>
            <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Hippocampal Volume - Left</title>
          <description>Determine the effect of a 6-month exercise program on hippocampal volume. An larger change from baseline to 6 months in left hippocampal volume (cubic millimeters) is considered an improvement.</description>
          <population>Of the total sample of 39 participants, 31 participants were able to undergo MRI scans. Of these, four participants did not complete the study. Good quality data, without motion distortion, were available in 21 participants (four participants were excluded due to motion distortion) at baseline and follow-up and were included in the analysis (9 intervention participants and 12 control participants).</population>
          <units>Cubic millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.0001" spread=".0002"/>
                    <measurement group_id="O2" value=".0" spread=".0001"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Home-based Walking Exercise</title>
          <description>Home-based exercise program: The exercise training group will participate in an educational session on exercise for CKD. Participants will receive a packet of information with an exercise prescription and a heart rate monitor that monitors the exercise. Participants will be asked to exercise (a brisk walk) at home, 3 times per week, for 30-60 minutes for 24 weeks. Participants will be contacted via phone biweekly or more frequently if they are behind the exercise routine, and the investigators will meet with them monthly to provide encouragement and progression of exercise, and to download the heart rate monitor.&#xD;
Partially supervised home-based walking exercise: Participants will be asked to exercise at home by walking at a moderate intensity. Each participant will receive an exercise prescription. Participants will receive a heart rate monitor. The heart rate monitors will be used to achieve a desired exercise intensity and to monitor adherence levels. The participants will receive biweekly to weekly phone calls, and monthly in person meetings will be used to address any barriers, provide encouragement, and progress the exercise.</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>The control group will receive standard instructions on exercise for patients with kidney disease similar to what is commonly done in clinical practice. The control group will not receive an exercise prescription or heart rate monitor. Participants will be contacted via phone biweekly to answer any questions and ensure continued study participation. The control group will not meet with the investigators monthly.&#xD;
Control: Participants will be asked to exercise at home by walking at a moderate intensity. The participants will receive biweekly phone calls, but will not receive a heart rate monitor, individual exercise prescription, or meet with the investigators monthly.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Transient ischemic attack</sub_title>
                <description>An intervention participant was diagnosed with a transient ischemic attack (TIA). It was determined that this event was unrelated to study procedures and that no protocol revisions were required. The participant was discontinued from the study.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ED visit: feeling of weakness</sub_title>
                <description>Possible anemia</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ED visit: non-specific chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>ED visit - blood pressure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Low ejection fraction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>ED visit: non-serious illness</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>ED visit - fall with head injury</sub_title>
                <description>Participant fell out of bed at home. Unrelated to study participation.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Home repair accident</sub_title>
                <description>Drywall well on participant.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Calf muscle soreness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Dental surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Prostate and hernia surgery</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Urgent care visit: Calf pain, possible DVT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ulf Bronas</name_or_title>
      <organization>University of Illinois at Chicago</organization>
      <phone>312-355-5886</phone>
      <email>bronas@uic.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

